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The effects on membranes of pardaxin, an amphipathic polypeptide, purified from the gland secretion of the Red Sea 
Moses sole flatfish Purdachirus marmoratus are dosedependent and range from formation of voltage-gated, cation-selec- 
tive pores to lysis. We have now investigated the interactions of pardaxin with small unilamellar liposomes. Light scatter- 
ing showed that pardaxin (10-7-10-9 M) mediated the aggregation of liposomes composed of phosphatidylserine but 
not of phosphatidylcholine. Aggregation of phosphatidylserine vesicles was impaired by vesicle depolarization. Further- 
more, pardaxin-mediated aggregation between fluorescent-labeled PS vesicles was accompanied by leakage of the vesicle 
contents, and not by fusogenic process within the aggregates. We suggest hat pardaxin is a unique polypeptide, that 
induces vesicle aggregation and membrane destabilization, but not membrane fusion; the mechanism of the aggregation 
activity of pardaxin is related to its amphipathic properties. 
Pardaxin; Phosphatidylserine vesicle; Phosphatidylserine aggregation 
1. INTRODUCTION 
Amphipathic polypeptides like gramicidin [ 11, 
alamethicin [2] or melittin [3] serve as general 
models for transmembrane channels or for pore 
forming membrane proteins. Recently, we have 
purified and characterized a novel pore forming, 
hydrophobic polypeptide from the secretion of the 
Red Sea Moses sole, named pardaxin [4]. 
Although its amino-terminal sequence differs from 
that of the pore forming polypeptides mentioned 
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above, the effects of pardaxin on membranes 
range similarly from an increase in the permeabili- 
ty to ions at low concentrations to lysis at high con- 
centrations [4-71. Furthermore, the increase in 
planar bilayer permeability by pardaxin was found 
to be voltage dependent [6] as is true for 
alamethicin [2] or melittin [3]. The detailed 
molecular structure of pardaxin pores and its in- 
teraction with artificial membranes are unknown. 
Thus, several questions about the interaction of 
pardaxin with artificial membranes remain: (i) Is 
its ability to produce aggregation related to its pore 
forming activity? (ii) Is the amino-terminal 
hydrophobic segment of pardaxin [4] sufficient to 
change membrane permeability and/or to induce 
phospholipid vesicle aggregation? (iii) Since 
vesicles pretreated with pardaxin form aggregates 
as qualitatively visualized under negative contrast 
electron microscopy [4], does this molecule qualify 
as a fusion protein? We have attempted to answer 
these questions by assaying for pardaxin induced 
aggregation and fusion of small unilamellar 
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liposomes using light scattering, fluorescence 
energy transfer techniques, respectively. Our 
results indicate that pardaxin will aggregate 
liposomes made of PS but not PC. However, while 
it causes significant leakage of vesicle contents, 
pardaxin does not induce membrane fusion. 
2. MATERIALS AND METHODS 
2.1. Materials 
Egg PC, PS from bovine brain, cholesterol and the fluores- 
cent lipids N-NBD-PE and N-Rho-PE were purchased from 
Avanti Polar Lipids (Birmingham, AL). ANTS, DPX and 
dansyl-PS were purchased from Molecular Probes (Junction Ci- 
ty, OR). Triton X-100 was purchased from Sigma (St. Louis, 
MO). The toxic secretion of the Red Sea Moses sole Par- 
dachirus marmoratus (Pisces, Soleidae) was obtained according 
to the method of Clark and Chao [S] and pardaxin was isolated 
as recently described [4]. The NHa-terminal segment of pardax- 
in: NHz-Gly-Phe-Phe-Ala-Leu-Ile-Pro-Gly-Ile-Glu-COOH was 
synthesized by the solid phase method [9]. 
All other chemicals were of the purest grade commercially 
available. 
2.2. Preparation of liposomes 
Small unilamellar liposomes composed of either pure PC or 
pure PS (5 mg/ml lipid concentration) were prepared according 
to established procedures [lo] by sonication to clarity of the tur- 
bid suspensions (lo-30 min) in a bath type sonicator 
(Laboratory Supplies, Inc., Hicksville, NJ). For most ex- 
periments the liposomes were prepared in PBS (Biofluids, 
Rockville, MD). Occasionally for studies involving membrane 
depolarization, the liposomes were made up in 150 mM KC1 or 
150 mM NaCl buffered with 10 mM Hepes and adjusted to pH 
7.2 with KOH or NaOH, respectively. Several types of fluores- 
cent liposomes were prepared, depending on the experimental 
requirements. For mixing of the lipid membranes and for ag- 
gregation studies, PC and PS (5 mg) in chloroform/methanol 
(1: 1) were mixed with 50 fig each of N-NBD-PE or N-Rho-PE 
[li] or with 100 cg dansyl-PS, respectively. The mixtures were 
evaporated under N2 to dryness and rehydrated in 1 ml of PBS. 
SUVs were then formed as described above. In order to measure 
mixing of the vesicle contents and leakage of the encapsulated 
dyes, liposomes were similarly prepared in 100 mM NaCl, 
12 mM ANTS or 45 mM DPX and the preformed ANTWDPX 
complex, respectively 112,131. Following sonication of the mix- 
tures the liposomes were purified by gel chromatography over 
PDlO (Pharmacia) columns equilibrated with CaZ+/Mg2’-free 
PBS. 
2.3. Spectroscopic assay 
All fluorescence measurements were performed at room 
temperature with a microprocessor controlled spec- 
trofluorimeter (Fluorolog 2, Spex Industries, Metuchen, NJ). 
The sample chamber was equipped with a magnetic stirrer. Ag- 
gregation of the liposomes was measured using two independent 
assays. In the first one we measured changes in 90” light scatter- 
ing at 340 nm using the spectrofluorimeter as a nephelometer. 
In the second assay the liposomes were labeled with 0.2 mol% 
132 
of dansyl-PS [14]. At this concentration the fluorescence of 
dansyl is essentially nonquenched. Since all the liposomes are 
labeled in their headgroup region, aggregation of the vesicles 
will result in a concentration dependent quenching of the 
fluorescence, as previously shown for other headgroup labeled 
lipids [15]. 
Vesicle fusion was measured using two independent fluores- 
cent assays for mixing of the vesicle contents and merging of the 
lipid bilayer membranes, respectively. The mixing of the con- 
tents was monitored using the ANTWDPX assay [12,13], incor- 
porating ANTS and DPX into different vesicle populations. 
ANTS fluorescence was measured at he, = 384; hem > 530. 
Merging of the membranes was assayed according to Struck 
et al. [ll]: 0.1 mol% each of NBD-PE and NBD-Rhodamine 
incorporated into the same vesicle membranes as fluorescence 
energy transfer donor and acceptor, respectively. NBD 
fluorescence was measured at 480 nm excitation and 530 nm 
emission with a 524 cuton filter in the emission light path. The 
excitation slits were kept narrow (1 mm) to reduce light scat- 
tering. 
Vesicle leakage was assayed by monitoring the increase in the 
ANTS fluorescence due to the pardaxin induced, lipid mem- 
brane permeability changes and subsequent diffusion and 
dissociation of the ANTWDPX, preincapsulated into the 
liposomes [ 121. 
2.4. Other methods 
Lipid concentrations were determined according to a 
modified Fiske-Subbarow method [16]. 
3. RESULTS 
3.1. Pardaxin-induced aggregation of 
phosphatidylserine vesicles 
The ability of pardaxin to cause aggregation of 
SUVs was tested by two different techniques. Ad- 
dition of pardaxin to a suspension of dansyl-PS 
labeled PS vesicles produced a rapid decrease in 
the fluorescence intensity (fig. 1). In contrast, when 
the same experiment was repeated using PC 
liposomes labeled with 0.2% mol dansyl-PS, no 
such quenching of fluorescence was observed (not 
shown). In a parallel set of experiments the effect 
of pardaxin on the 90” light scattering properties 
of SUVs were investigated (fig.2). Addition of 3 x 
10v7 M PX to PC liposomes did not significantly 
change the light scattering signal (fig.ZA). In con- 
trast, adding of pardaxin to PS vesicles produces a 
rapid decrease in the light scattering signal which 
was followed by a slow, gradual increase (fig.2A). 
Qualitatively, similar, but far less pronounced ef- 
fects were observed when using lOO-fold higher 
concentration of the synthetic amino-terminal 
decapeptide (fig.2B). These results suggest hat the 
intact pardaxin molecule, not only its synthetic 
Volume 230, number 1,2 FEBS LETTERS March 1988 
I I 
0 100 2w 
Time Isac) 
Fig.1. Pardaxin-induced aggregation of PS vesicles labeled with 
dansyl-PS. Dansyl labeled (20 PM) liposomes were incubated in 
150 mM KCI, 10 mM Hepes buffer, pH 7.2. The fluorescence 
of the lipid probe at this concentration is unquenched. Upon 
addition of pardaxin (PX, arrow) the fluorescence intensity is 
quenched by about 40% indicative of aggregation. 
amino terminal decapeptide can aggregate 
phosphatidylserine vesicles, but not phosphatidyl- 
choline vesicles. 
The same techniques were used to explore the ef- 
fects of the liposomal transmembrane potential on 
pardaxin induced liposome aggregation. 
Gramicidin ( 10M8 M) was added to liposomes load- 
ed with 150 mM NaCl to generate a membrane 
potential (fig.ZC) which was positive on the exter- 
nal face of the membrane. Generation of a positive 
potential significantly reduced the rate of 
pardaxin-induced aggregation of PS vesicles com- 
pared to that of non-treated PS liposomes (fig.2C). 
These results were independent of the species of 
monovalent cations and/or of the ionophore used 
since similar results were obtained when the same 
potential was generated using either monensin as a 
Na+ ionophore, or KCl-loaded liposomes and 
valinomycin as a specific K+ ionophore (not 
shown). 
3.2. Evaluation of pardaxin-mediated leakage of 
vesicle content and possible vesicle-vesicle 
fusion 
Previously we have shown that pardaxin is a 
pore forming polypeptide [4,5]. We therefore 
measured the effects of pardaxin on the leakage of 




Fig.2. Light scattering measurements of liposomal aggregation, 
induced by pardaxin (A) and the synthetic decapeptide (B) and 
the effect of gramicidin-induced liposomal diffusion potential 
on pardaxin-mediated aggregation of phosphatidylserine 
liposomes (C). (A,B) 100/M phosphatidylserine (PS) or 
phosphatidylcholine (PC) SUV were incubated in PBS, pH 7.3, 
3 x lo-’ pardaxin (A) or 4 x 10m5 M, NHz-terminal synthetic 
decapeptide (B) were added. 90” light scattering of the 
suspension was measured as described in section 2. (C) lo-* M 
gramicidin was added to a sample of PS, Na+ loaded liposomal 
suspension (1OOpM) in 0.3 M sucrose, 3 mM Tris, pH 7.3, 
therefore inducing an inside/outside NaC concentration 
gradient [35]. This gradient produces a positive charge on 
external liposomal surface. 2 min after gramicidin addition, 
3 x lo-’ M pardaxin (PX, arrow) was added and the 
aggregation of vesicles was monitored by light scattering at 
340 nm. 
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ANTUDPX complex. Pardaxin below lo-” M 
did not induce vesicle leakage. At pardaxin con- 
centrations between 10v9 and lo-* M there was a 
small, slow leakage of ANTS/DPX; at lo-’ M 
pardaxin and above the rate and extent of leakage 
increased dramatically (fig.3). However, pardaxin- 
induced leakage was not complete even at 10m6 M 
since disruption of the vesicles after addition of 
0.1% (v/v) Triton X-100 increased further the 
fluorescence signal (fig.3). 
Polypeptides that aggregate PS liposomes and 
concomitantly induce leakage are likely to be 
fusogenic [17,18]. To test this hypothesis we 
assayed for liposome fusion using two independent 
techniques which measured the mixing of the con- 
tents and merging of the membranes, respectively. 
Pardaxin at concentrations exceeding low8 M, in- 
duced a small, but measurable leakage of the vesi- 
cle contents, as shown above. However, there was 
no measurable mixing of contents using the 
ANTWDPX fusion assay (fig.4A). The presence 
of 10e8 M pardaxin did not impair the fusion com- 
petence of these liposomes since subsequent addi- 
tion of 2 mM calcium induced membrane fusion 
manifested by the decrease in ANTS fluorescence 
upon mixing of the vesicle contents (fig.4A). 
In some systems, hemifusion of liposomes has 
been demonstrated in which the outer monolayer 
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Fig.4. Pardaxin does not induce PS vesicle fusion. Fusion of PS 
vesicles was independently assayed using two complementary 
techniques: (A) mixing of vesicle content; (B) mixing of 
membrane lipids. (A) SUV, PS vesicles containing 
12 mM/ANTS and 45 mM/DPX, respectively, were prepared 
by sonication and purified by gel chromatography. The fusion 
assays were performed as described [12,13]. 20 PM each of 
ANTS and DPX containing SUVs were incubated in 150 mM 
KCl, 10 mM Hepes buffer, pH 7.2. Addition of 10-s M 
pardaxin (PX, arrow) caused a minor decrease in the 
fluorescence, probably due to leakage (cf. fig.3). However, 
addition of 2 mM Ca’+ resulted in a time-dependent reduction 
in the fusion signal, typical for the occurrence of membrane 
fusion. (B) SUV, PS vesicles containing 0.1 mol% each, NBD- 
Rhodamine PS in the membranes were prepared by sonication. 
Coincubation of 10pM of the labeled vesicles with a 5-fold 
excess of unlabeled PS-SUV (arrow, PS) did not change the 
fluorescence of the donor. Similarly, addition of up to lo-’ M 
pardaxin (PX, arrows) did not alter NBD fluorescence. The 
slight increase in NBD fluorescence at 1Om6 M pardaxin is 
probably related to its surfactant properties [20]. However, this 
surfactant property did not cause sizable disruption of the 
membrane as seen from the steep increase in NBD fluorescence 
upon addition of 0.1% Triton X-100. The fusogenic properties 
of these vesicle preparations is shown in the inset. Addition of 
5 mM Cazf induced a rapid mixing of the membranes resulting 
in the increase in NBD fluorescence. Addition of 0.1% (v/v) 
Fig.3. Pardaxin-induced leakage of PS vesicles. PS liposomes 
were loaded with ANTS/DPX during sonication and purified 
by gel filtration as described in section 2. Liposomes, 20 pM, 
were incubated in 150 mM KCl, 10 mM Hepes buffer, pH 7.2, 
and pardaxin was added at the times and concentrations 
indicated in the figure. The first evidence for leakage was 
noticed at lo-* M. Vesicle lysis was not complete even at 
10m6 M pardaxin since addition of 0.1% (v/v) Triton X-100 
induced additional release of the ANTWDPX complex. Triton X-100 yielded maximal NBD dilution. 
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lipids merge effectively without concomitant mix- 
ing of vesicle contents [ 191. To test this possibility, 
PS liposomes doped with NBD-PE and Rhoda- 
mine-PE were used in a lipid mixing assay [21]. 
Addition of pardaxin, up to 10v6 M, did not in- 
duce mixing of the membrane lipids of PS 
liposomes, as ascertained by the NBD/Rhodamine 
assay (fig.4B). Control liposomes were shown to 
undergo fusion upon addition of 5 mM calcium 
(fig.4B, inset). Previous studies have indicated that 
at these high concentrations pardaxin might act as 
a surfactant [20]; however, its mechanism of ac- 
tion seems to differ from that of other detergents, 
such as Triton, which completely disrupt the 
vesicles, resulting in an abrupt increase in the NBD 
fluorescence [21]. 
4. DISCUSSION 
Pardaxin is a well characterized single chain, 
amphipathic polypeptide [4-7,9] which readily in- 
teracts with biological and artificial lipid mem- 
branes. Pardaxin binds to and spontaneously 
inserts into the membranes to form voltage-gated 
pores [4-71. In this study we present evidence that 
pardaxin rapidly aggregates phosphatidylserine 
(but not phosphatidylcholine liposomes) in a 
voltage-dependent fashion, and induces membrane 
destabilization, as manifested by the leakage of 
their contents, and yet our results clearly 
demonstrate that pardaxin does not fuse PS 
liposomes. In this respect, pardaxin differs from 
another pore forming oligopeptide, alamethicin, 
which was shown to fuse phosphatidylcholine 
liposomes [22]. Our results seem even more unex- 
pected, since membrane aggregation and 
destabilization have hitherto been interpreted as 
being characteristic for fusogenic molecules such 
as Ca2+ [23], polylysine [24] or for oligopeptides, 
such as mellitin [17] or a synthetic copolymer of 
glutamic acid-alanine-leucine-alanine [25]. 
True membrane fusion, as opposed to hemifu- 
sion [26] requires besides membrane destabiliza- 
tion mixing of both the membrane lipids and the 
vesicle contents [27]. Using a non-lytic concentra- 
tion of 10m8 M pardaxin, we clearly demonstrate 
that aggregation of the liposomes is accompanied 
by a slight leakage of the vesicle contents (fig.3) 
without concomitant merging of the bilayer mem- 
branes and mixing of the liposomal contents 
(fig.4). However, pardaxin-aggregated liposomes 
remain sensitive to calcium triggered fusion (fig.4). 
Therefore, under our experimental conditions, 
pardaxin neither resembles calcium/membrane 
binding proteins which inhibit liposome fusion, 
such as prothrombin, parvalbumin or calmodulin 
[28] nor does it belong to the class of fusion pro- 
teins, like clathrin [29] or synexin [30,31] which 
were shown to induce and/or enhance fusion of ar- 
tificial and biological membranes. 
Close inspection of the molecular structure of 
pardaxin reveals that this oligopeptide contains a 
single hydrophobic, helical segment at the amino 
terminal; by contrast, the carboxy-terminal is com- 
posed mainly of charged amino acids (serine, 
glycine, glutamic acid), rendering this portion of 
the molecule highly hydrophilic [6]. In line with 
previous findings and computer modeling [9], we 
propose, that, while the hydrophobic segment will 
be easily inserted into lipid membranes (pore for- 
mation), the aggregation properties of pardaxin 
are due to electrostatic interactions of the carboxy- 
terminus with neighboring acidic liposomes. Hence 
the preference of PS over PC and the modulating 
role of the transmembranal electrical potential 
(fig.2). 
However, to induce membrane destabilization 
and ultimately fusion, it does not seem to suffice 
to aggregate neighboring membrane surfaces via 
hydrostatic interactions. Rather, fusion requires 
both dehydration and membrane destabilization as 
suggested for the fusogenic action of calcium 
[23,26] and also that of viral glycoproteins [32,33]. 
Pardaxin, however, seems to lack a second 
hydrophobic domain which could insert into op- 
posing bilayers to further destabilize and fuse the 
aggregated membrane complexes. Such multiple 
hydrophobic domains have been found in, e.g., 
synexin [34], which indeed aggregates and fuses 
chromaffin granules [31]. We believe that con- 
tinued studies of amphipathic, lipid binding pro- 
teins, such as pardaxin, which do aggregate and 
destabilize, but do not fuse lipid membranes, will 
eventually contribute to our understanding of the 
molecular basis required for protein-mediated fu- 
sion in biological systems. 
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